“…They have emerged as the most promising platform, as short peptides of interest can be integrated into a nanovaccine in tandem with SAPs such as Q11 (J. Chen et al, 2013; Chesson et al, 2014; Pompano et al, 2014), or KFE8 that assembles into β‐sheet rich nanofibers in physiological buffer (Mora‐Solano et al, 2017; Rudra, Ding et al, 2016). In addition, SAP‐based nanofibers can be generated bearing different epitopes via noncovalent self‐assembly of SAP that are synthesized in tandem with defined epitopes (Chesson et al, 2018; Pompano et al, 2014). SAP‐based nanofibers have recently gained increased attention as vaccine platform for the application in infectious and noninfectious diseases (Mora‐Solano et al, 2017; Rudra, Ding et al, 2016; Si et al, 2018; Trent et al, 2015).…”